Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 638, pseudogene (RNU6-638P)
- Target
- RNU6-638P
- Molecular classification
- Other (pseudogene; non-coding RNA pseudogene derived from a small nuclear RNA gene)
01
Overview
RNU6-638P is a pseudogene associated with the U6 small nuclear RNA gene family[2][6]. Pseudogenes are non-functional sequences resulting from genomic duplication or retrotransposition of functional genes. RNU6-638P does not encode active U6 snRNA and is not incorporated into the spliceosome or associated with splicing. Unlike functional U6 snRNA, which plays a catalytic role in spliceosome assembly and intron excision in eukaryotic cells[1][3], pseudogenes such as RNU6-638P serve as evolutionary remnants and do not participate in known biological processes, disease roles, or drug interactions[2][6][5]. There is no evidence supporting its use as a therapeutic target, biomarker, or drug interaction site.\n\nIn summary, RNU6-638P is a non-functional, non-coding RNA pseudogene of U6 snRNA origin and should not be considered a therapeutic target or associated with clinical pharmacology[2][6][5].
- Other names
- RNU6-638PRNA, U6 small nuclear 638, pseudogene
Beyond the preview
Go deeper on RNA, U6 small nuclear 638, pseudogene (RNU6-638P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 638, pseudogene (RNU6-638P).